The UK’s COVID-19 antibody tests program continues to follow two tracks, the development of lab-based tests and home use/self-test finger prick (lateral flow test, LFT) devices. But Tim Brown, the rec
Pillars one and two of the UK’s national testing strategy for COVID-19 announced on 2 April focus on antigen testing ̶ confirmatory tests for those who currently have the virus. Though the size of the
Device Transactions Device financing during 2015's third quarter reached $1.4 billion, a 22% dip from Q2's $1.8 billion total. ( See Exhibit 1. ) Late-stage venture capital rounds represented most of